×
About 250,842 results

ALLMedicine™ Type 2 Diabetes Center

Research & Reviews  114,395 results

Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark.
https://doi.org/10.1186/s13073-021-00851-9 10.7150/ijms.10001 10.1016/S0140-6736(05)61032-X 10.3390/genes6010087 10.1056/NEJMra1600266 10.1038/nature11450 10.1371/journal.pone.0009085 10.1038/pr.2014.170 10.2174/0929867324666171009121702 10.1371/journal.pone.0071108 10.1111/j.1749-6632.2012.06838.x 10.2337/db13-1592 10.1161/01.CIR.104.2.145 10.1210/jc.2003-030301 10.1007/s11010-008-9996-x 10.1038/ijo.2011.185 10.3389/fmicb.2016.00660 10.1038/s41598-018-28550-3 10.1371/journal.pone.0195643 10.1371/journal.pone.0199640 10.3389/fmicb.2017.00214 10.4103/2230-8210.183474 10.2337/dc08-1195 10.1016/S0140-6736(12)60525-X 10.1056/NEJMoa012512 10.2337/dc16-1241 10.1016/j.trsl.2015.06.015 10.1007/s00125-018-4550-1 10.1530/EC-15-0094 10.1186/s40168-018-0472-x 10.2147/CLEP.S129335 10.1186/1471-2458-12-1078 10.1128/AEM.63.7.2802-2813.1997 10.1016/j.mimet.2010.08.008 10.1038/nmeth.3869 10.1038/nmeth.f.303 10.1128/AEM.03006-05 10.1093/bioinformatics/btq461 10.1093/nar/gkm864 10.1038/nbt.2676 10.1371/journal.pone.0148347 10.1371/journal.pone.0061217 10.1186/s13059-014-0550-8 10.1016/S0140-6736(12)60283-9 10.3389/fmicb.2016.01945 10.1186/s40168-017-0231-4 10.1073/pnas.1102715108 10.1038/srep18507 10.1073/pnas.0804812105 10.1038/ncomms7528 10.1016/S0091-6749(98)70080-6 10.1089/jir.2008.0027 10.1111/j.1365-2249.2006.03085.x 10.1152/ajpendo.00571.2013 10.1016/j.cyto.2011.09.029 10.1038/ijo.2011.256 10.1155/2013/678159 10.2174/092986707780831131 10.1111/j.1600-065X.2008.00705.x 10.1128/IAI.67.8.3824-3829.1999 10.1186/s12933-017-0545-3 10.1016/j.ijbiomac.2017.07.155 10.1016/j.imlet.2018.01.014 10.1155/2017/9074601 10.1038/nature11053 10.1016/j.celrep.2015.03.049 10.1073/pnas.1005963107 10.1177/1756283X13482996 10.1080/00365520802433231 10.1038/srep18563 10.3389/fmicb.2017.01162 10.1038/s41591-018-0160-1 10.1038/s41598-017-11215-y 10.1186/s13059-017-1194-2 10.3389/fmicb.2016.00200 10.1016/j.immuni.2016.02.019 10.1016/j.cmet.2015.10.001 10.1038/nrgastro.2016.4 10.1038/nature18646 10.1016/j.cell.2018.02.044 10.1038/srep46337 10.1039/b914182k 10.3389/fmicb.2016.01934 10.1097/MD.0000000000004803 10.1186/s13073-016-0271-6
Genome Medicine; Pinna NK, Anjana RM et. al.

Mar 4th, 2021 - Recent studies have indicated an association of gut microbiota and microbial metabolites with type 2 diabetes mellitus (T2D). However, large-scale investigation of the gut microbiota of "prediabetic" (PD) subjects has not been reported. Identifyin...

n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level...
https://doi.org/10.2337/dc20-2426
Diabetes Care; Qian F, Ardisson Korat AV et. al.

Mar 4th, 2021 - Prospective associations between n-3 fatty acid biomarkers and type 2 diabetes (T2D) risk are not consistent in individual studies. We aimed to summarize the prospective associations of biomarkers of α-linolenic acid (ALA), eicosapentaenoic acid (...

Lifestyle intervention improves prothrombotic coagulation profile in individuals at hig...
https://doi.org/10.1210/clinem/dgab124
The Journal of Clinical Endocrinology and Metabolism; Hörber S, Lehmann R et. al.

Mar 4th, 2021 - Patients with obesity and insulin resistance are at higher risk for arterial and venous thrombosis due to a prothrombotic state. If this is reversible by lifestyle intervention was addressed in the current study and potential underlying associatio...

see more →

Guidelines  401 results

Drug activates brown fat, improves glucose metabolism in healthy women
https://www.nih.gov/news-events/nih-research-matters/drug-activates-brown-fat-improves-glucose-metabolism-healthy-women
National Institutes of Health (NIH)

Feb 3rd, 2021 - The majority of adults in the U.S. carry too much fat in their bodies and are now considered overweight or obese. The last several decades have also seen a spike in related diseases of metabolism, such as type 2 diabetes.

Brown fat associated with less heart and metabolic disease
https://www.nih.gov/news-events/nih-research-matters/brown-fat-associated-less-heart-metabolic-disease
National Institutes of Health (NIH)

Feb 1st, 2021 - Too much white fat, a characteristic of obesity, has been shown to increase the risk of type 2 diabetes, high blood pressure, and other diseases. A less common type of fat, called brown fat, uses blood sugar and fat molecules to create heat and he...

Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785422/
Obesity Medicine; Pang J, Liu M et. al.

Jan 5th, 2021 - COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, type 2 di...

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
https://pubmed.ncbi.nlm.nih.gov/33198768/
BMC Medicine; Escala-Garcia M

Nov 16th, 2020 - Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mend...

Comparative Performances of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Gout in Type 2 Diabetes
https://www.rheumatologyadvisor.com/home/conference-highlights/acr-convergence-2020/comparative-performance-of-sglt2-inhibitors-in-reducing-gout-in-t2d/

Nov 8th, 2020 - Among patients with type 2 diabetes (T2D), sodium-glucose cotransporter-2 (SGLT2) inhibitors dapagliflozin and empagliflozin vs canagliflozin show greater benefit in reducing gout, according to research results presented at the American College of...

see more →

Drugs  2,561 results see all →

Clinicaltrials.gov  123,839 results

Glimepiride - glimepiride tablet-Solco Healthcare U.S., LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86acdd9e-8637-43e4-8bf7-b3a123b871b8

Aug 12th, 2021 - Glimepiride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ]. Limitations of Use Glimepiride tablets USP should not be used for the trea...

Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark.
https://doi.org/10.1186/s13073-021-00851-9 10.7150/ijms.10001 10.1016/S0140-6736(05)61032-X 10.3390/genes6010087 10.1056/NEJMra1600266 10.1038/nature11450 10.1371/journal.pone.0009085 10.1038/pr.2014.170 10.2174/0929867324666171009121702 10.1371/journal.pone.0071108 10.1111/j.1749-6632.2012.06838.x 10.2337/db13-1592 10.1161/01.CIR.104.2.145 10.1210/jc.2003-030301 10.1007/s11010-008-9996-x 10.1038/ijo.2011.185 10.3389/fmicb.2016.00660 10.1038/s41598-018-28550-3 10.1371/journal.pone.0195643 10.1371/journal.pone.0199640 10.3389/fmicb.2017.00214 10.4103/2230-8210.183474 10.2337/dc08-1195 10.1016/S0140-6736(12)60525-X 10.1056/NEJMoa012512 10.2337/dc16-1241 10.1016/j.trsl.2015.06.015 10.1007/s00125-018-4550-1 10.1530/EC-15-0094 10.1186/s40168-018-0472-x 10.2147/CLEP.S129335 10.1186/1471-2458-12-1078 10.1128/AEM.63.7.2802-2813.1997 10.1016/j.mimet.2010.08.008 10.1038/nmeth.3869 10.1038/nmeth.f.303 10.1128/AEM.03006-05 10.1093/bioinformatics/btq461 10.1093/nar/gkm864 10.1038/nbt.2676 10.1371/journal.pone.0148347 10.1371/journal.pone.0061217 10.1186/s13059-014-0550-8 10.1016/S0140-6736(12)60283-9 10.3389/fmicb.2016.01945 10.1186/s40168-017-0231-4 10.1073/pnas.1102715108 10.1038/srep18507 10.1073/pnas.0804812105 10.1038/ncomms7528 10.1016/S0091-6749(98)70080-6 10.1089/jir.2008.0027 10.1111/j.1365-2249.2006.03085.x 10.1152/ajpendo.00571.2013 10.1016/j.cyto.2011.09.029 10.1038/ijo.2011.256 10.1155/2013/678159 10.2174/092986707780831131 10.1111/j.1600-065X.2008.00705.x 10.1128/IAI.67.8.3824-3829.1999 10.1186/s12933-017-0545-3 10.1016/j.ijbiomac.2017.07.155 10.1016/j.imlet.2018.01.014 10.1155/2017/9074601 10.1038/nature11053 10.1016/j.celrep.2015.03.049 10.1073/pnas.1005963107 10.1177/1756283X13482996 10.1080/00365520802433231 10.1038/srep18563 10.3389/fmicb.2017.01162 10.1038/s41591-018-0160-1 10.1038/s41598-017-11215-y 10.1186/s13059-017-1194-2 10.3389/fmicb.2016.00200 10.1016/j.immuni.2016.02.019 10.1016/j.cmet.2015.10.001 10.1038/nrgastro.2016.4 10.1038/nature18646 10.1016/j.cell.2018.02.044 10.1038/srep46337 10.1039/b914182k 10.3389/fmicb.2016.01934 10.1097/MD.0000000000004803 10.1186/s13073-016-0271-6
Genome Medicine; Pinna NK, Anjana RM et. al.

Mar 4th, 2021 - Recent studies have indicated an association of gut microbiota and microbial metabolites with type 2 diabetes mellitus (T2D). However, large-scale investigation of the gut microbiota of "prediabetic" (PD) subjects has not been reported. Identifyin...

n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level...
https://doi.org/10.2337/dc20-2426
Diabetes Care; Qian F, Ardisson Korat AV et. al.

Mar 4th, 2021 - Prospective associations between n-3 fatty acid biomarkers and type 2 diabetes (T2D) risk are not consistent in individual studies. We aimed to summarize the prospective associations of biomarkers of α-linolenic acid (ALA), eicosapentaenoic acid (...

see more →

News  9,567 results

Glucocorticoids Linked to Higher Mortality Rates in Patients with RA and Diabetes
https://www.medscape.com/viewarticle/946930

Mar 4th, 2021 - Takeaway Glucocorticoid (GC) use was associated with higher mortality rates in patients with rheumatoid arthritis (RA) and concomitant type 2 diabetes (T2D) vs patients with RA who did not have T2D, despite apparently reassuring similar relative r...

Type 2 Diabetes Subtypes and Risks Related to Race, Ethnicity
https://www.medscape.com/viewarticle/946106

Mar 2nd, 2021 - This transcript has been edited for clarity. A topic that has always interested me is the notion that there is more than one type of type 2 diabetes. Throughout my career, I've seen patients from all walks of life and places all around the world —...

Some Patients With Type 2 Diabetes Have Major ECG Abnormalities
https://www.medscape.com/viewarticle/946699

Mar 1st, 2021 - Major ECG abnormalities were found in 13% of more than 8,000 unselected patients with type 2 diabetes, including a 9% prevalence in the subgroup of these patients without identified cardiovascular disease (CVD) in a community-based Dutch cohort. M...

Less Risk of Severe Hypoglycemia With Long-Acting Insulin Analogs in Elderly
https://www.medscape.com/viewarticle/946662

Mar 1st, 2021 - NEW YORK (Reuters Health) - Long-acting insulin analogs may be a safer option than neutral protamine Hagedorn (NPH, also known as isophane insulin) in elderly patients with type 2 diabetes initiating insulin therapy, according to a large observati...

Goldenseal May Interfere With Metformin, Jeopardize Glucose Control
https://www.medscape.com/viewarticle/946380

Feb 23rd, 2021 - Goldenseal, a natural botanical product, may interfere with intestinal absorption of metformin, potentially compromising blood glucose control in patients with type 2 diabetes, according to investigators. The study, which tested for interactions b...

see more →

Patient Education  79 results see all →